Janux Therapeutics Inc., a clinical-stage biopharmaceutical company developing a pipeline of novel immunotherapies, has appointed William Go, M.D., Ph.D., as its Chief Medical Officer (CMO). Go succeeds Zachariah McIver, D.O., Ph.D., who will be leaving the company to pursue other opportunities. “Janux is entering an important new phase as our programs advance and the complexity of our clinical and regulatory efforts increases,” said David Campbell, Ph.D., President and CEO of Janux Therap...